Immunocore Holdings plc
IMCR
$30.04
-$0.69-2.25%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -30.06M | -177.00K | -10.30M | 5.02M | -23.77M |
| Total Depreciation and Amortization | 834.00K | 798.00K | 780.00K | 854.00K | 1.17M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 23.67M | -3.75M | 8.75M | 2.17M | 13.08M |
| Change in Net Operating Assets | -27.10M | -1.32M | 26.74M | -7.61M | -4.43M |
| Cash from Operations | -32.66M | -4.46M | 25.96M | 435.00K | -13.95M |
| Capital Expenditure | -2.88M | -748.00K | -414.00K | -298.00K | -3.58M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 44.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.00M | 6.00M | -30.00M | 10.00M | 0.00 |
| Cash from Investing | -880.00K | 5.25M | -30.41M | 9.70M | -3.54M |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -52.06M |
| Issuance of Common Stock | 4.28M | 1.87M | 3.67M | 2.55M | 550.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Financing | 4.28M | 1.87M | 3.67M | 2.55M | -51.51M |
| Foreign Exchange rate Adjustments | -1.45M | 7.82M | 11.87M | 8.43M | -13.03M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -30.70M | 10.48M | 11.09M | 21.11M | -82.04M |